|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
D04.4 |
Carcinoma in situ of skin of scalp and neck
|
D044 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 49.25%
|
23.74%
|
9.43%
|
5.45%
|
3.16%
|
2.50%
|
1.92%
|
1.28%
|
1.01%
|
0.64%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D04.4*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
3,506
|
5,396
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,702
|
1,709
|
|
17311
|
MOHS 1 STAGE H/N/HF/G |
1,376
|
1,429
|
|
11102
|
TANGNTL BX SKIN SINGLE LES |
842
|
842
|
|
17000
|
DESTRUCT PREMALG LESION |
763
|
763
|
|
17003
|
DESTRUCT PREMALG LES 2-14 |
662
|
2,159
|
|
17272
|
DSTR MAL LES S/N/H/F/G 1.1-2 |
530
|
567
|
|
17312
|
MOHS ADDL STAGE |
478
|
534
|
|
11103
|
TANGNTL BX SKIN EA SEP/ADDL |
368
|
525
|
|
17271
|
DSTR MAL LES S/N/H/F/G 0.6-1 |
318
|
349
|
|
12042
|
INTMD RPR N-HF/GENIT2.6-7.5 |
245
|
245
|
|
13121
|
CMPLX RPR S/A/L 2.6-7.5 CM |
223
|
223
|
|
12032
|
INTMD RPR S/A/T/EXT 2.6-7.5 |
200
|
200
|
|
88331
|
PATH CONSLTJ SURG 1 BLK 1SPC |
193
|
312
|
|
17110
|
DESTRUCT B9 LESION 1-14 |
183
|
183
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
183
|
213
|
|
11622
|
EXC S/N/H/F/G MAL+MRG 1.1-2 |
169
|
170
|
|
13132
|
CMPLX RPR F/C/C/M/N/AX/G/H/F |
150
|
150
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
146
|
3,923
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
134
|
340
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D04.4 related to the following DRG Codes:
606-607
|
